A carregar...
Recombinant human erythropoietin does not affect several microvascular parameters in well‐trained cyclists
Recombinant human erythropoietin (rHuEPO) has been used as a performance‐enhancing agent by athletes in a variety of sports. The resulting increase in hematocrit levels leads to increased blood viscosity and can affect blood flow, potentially increasing the athlete's risk of developing health c...
Na minha lista:
| Publicado no: | Physiol Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6308108/ https://ncbi.nlm.nih.gov/pubmed/30592183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.13924 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|